SwedenLivingWorldBusinessSportsEntertainment

Biogen

Sweden Advises Against Costly New ALS Drug Due to Limited Benefits
Sweden News

Sweden Advises Against Costly New ALS Drug Due to Limited Benefits

The regions are advised against using a new medication for the nervous disease ALS. The treatment is deemed too expensive and not to have any tangible impact on the patients
Upwards on Wall Street – major companies recovered
Business News

Upwards on Wall Street – major companies recovered

The trading week on Wall Street ended in major, after many large technology companies had a shaky week.
Alzheimer's drug rejected by EMA
Sweden News

Alzheimer's drug rejected by EMA

The Alzheimer's drug lecanemab has not been approved by the European Medicines Agency EMA. The benefits are not considered to outweigh the potential drawbacks
Show Consent Options

Categories

Information

Sweden Herald

  • Stay informed with the latest news and updates from Sweden in English. From daily news and events happening now, to recaps of what happened in Sweden last night, our coverage keeps you updated. Swedish news today.
  • © Sweden Herald